During the early stages of the pandemic, SPAC mergers were the route that many medtech companies took to go public.
Medtronic made headlines twice this week. First, the company launched its MiniMed 780G insulin pump system integrated with Abbott’s Instinct sensor technology. Then, FDA cleared the company’s Hugo ...
The medtech startup competes against larger players in the intravascular lithotripsy space, which include Johnson & Johnson ...
The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional ...
Trelleborg opens its first Central American facility in Costa Rica, enhancing medical device production and sustainability.
The long-awaited FDA clearance sets up a showdown in the surgical robotics market between Medtronic and Intuitive Surgical.
Medtronic launches MiniMed 780G with Abbott sensor integration, expanding its diabetes ecosystem ahead of a planned spinoff.
Boston Scientific faces intense competition from major players such as Medtronic, Johnson & Johnson, and Abbott Laboratories.
The Waltham, MA-based company said it now expects a full-year 2025 cash burn rate of about $45 million, down from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback